Alkermes, Inc. is a biopharmaceutical company based in Massachusetts. It lobbies on health-related issues, especially matters affecting Medicare and Medicaid and federal responses to the opioid and mental illness epidemics, citing implementation of the Comprehensive Addiction and Recovery Act. Filings show it spent about $220,000 and used Thorn Run Partners for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ALEX DELPIZZO
The latest disclosures for this client.
THORN RUN PARTNERS
Q2THORN RUN PARTNERS
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THORN RUN PARTNERS
GARY PALMQUIST
THORN RUN PARTNERS
THORN RUN PARTNERS
Q4THORN RUN PARTNERS
Q3THORN RUN PARTNERS
Q2THORN RUN PARTNERS
Q1